The global injectable drug delivery market size is expected to reach USD 1,227.92 Billion by 2028 at a CAGR of 11.3%, according to a new report by Reports and Data. Market revenue growth is majorly driven by rising prevalence of chronic diseases such as diabetes, cancer, and various autoimmune diseases, development of advanced biologics, technological innovations in injectable device design, and rising adoption of injectable drug delivery systems due to several advantages such as ease of use, lesser pain, and enhanced safety. Increasing use of self-injectable devices due to several benefits such as convenient use, cost-effectiveness, and high-precision drug delivery is another major factor accountable for the global market growth.
Injectable drug delivery refers to intravenous or subcutaneous administration of drugs and uses injectable devices for drug delivery. The injectable method is one of the most effective drug delivery methods and is most suitable for drugs that have poor oral bioavailability. This drug delivery method is most widely used for conditions including hormonal imbalance, autoimmune diseases, cystic fibrosis, hemophilia, Wilson’s disease, and hepatitis C. Over the years, the development of self-injection devices such as pen-injectors, auto-injectors, and needle-free injectors, has made it quite easy for patients to administer drugs at home without any professional assistance. Furthermore, emerging drug delivery technologies such as dual-injectables are rapidly gaining traction globally, with the growing need for advanced patient care.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1382
The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.
Key companies operating in the market include:
Baxter International, Nova Nordisk A/S, Becton Dickinson, Sanofi, Pfizer, InjexPharma GmbH, Terumo Corporation, Unilife Corporation, Gerresheimer AG, Vetter Pharma-Fertigung GmbH Co. KG., Schott AG, and Eli Lily Company.
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1382
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Injectable Drug Delivery market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the Injectable Drug Delivery industry, the market is segmented into:
Type Outlook (Revenue, USD Billion; 2020-2028)
- Formulation
- Conventional drug delivery (solutions, reconstituted/ lyophilized formulations, suspensions)
- Novel drug delivery (colloidal dispersions and nanoparticles)
- Others
- Devices
- Self-injectable devices (auto-injectors, needle-free injectors, pen injectors, and others)
- Conventional injection devices
Application Outlook (Revenue, USD Billion; 2020-2028)
- Hormonal Disorders
- Autoimmune Diseases
- Oncology Disorders
- Orphan Diseases
- Diabetes
- Others
End-use Outlook (Revenue, USD Billion; 2020-2028)
- Hospitals
- Clinics
- Ambulatory Care Centers
- Home Care Centers
- Clinical and Diagnostic Laboratories
- Research Institutes
- Others
The regional analysis covers:
- North America
- US.
- Canada
- Mexico
- Europe
- Germany
- UK.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/injectable-drug-delivery-market
Benefits of Injectable Drug Delivery Market Report:
- Panoramic overview of the opportunities and risks in the Injectable Drug Delivery sector
- Study of recent innovations and developments in the industry
- Comprehensive study of the growth pattern of the Injectable Drug Delivery industry
- In-depth assessment of the competitive landscape of the key players of the Injectable Drug Delivery industry
- Analysis of the Injectable Drug Delivery market drivers, constraints, and opportunities
- Assessment of technological developments and latest trends of the industry
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1382
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
Browse More Reports :
Healthcare Equipment Leasing Market @https://www.reportsanddata.com/report-detail/healthcare-equipment-leasing-market
Cell and Tissue Preservation Market @ https://www.reportsanddata.com/report-detail/cell-and-tissue-preservation-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
